Translational Development Acqui (TDAC)
NGM · Financial Services · Shell Companies
$10.72
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$234.8M
Exchange
NGM
About Translational Development Acqui
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -221K | -214K | -162K | -281K |
| Net Income | 1.6M | 1.7M | 1.6M | 1.3M |
| Diluted EPS | $0.07 | $0.08 | $nan | $0.06 |
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Operating Income | -486K | -196K | -945K |
| Net Income | -486K | -71K | 6.4M |
| Diluted EPS | $-0.11 | $-0.02 | $nan |